1. Home
  2. BGLC vs SPPL Comparison

BGLC vs SPPL Comparison

Compare BGLC & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • SPPL
  • Stock Information
  • Founded
  • BGLC 2017
  • SPPL 2016
  • Country
  • BGLC Malaysia
  • SPPL Singapore
  • Employees
  • BGLC N/A
  • SPPL N/A
  • Industry
  • BGLC Medical Specialities
  • SPPL
  • Sector
  • BGLC Health Care
  • SPPL
  • Exchange
  • BGLC Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • BGLC 10.7M
  • SPPL 9.8M
  • IPO Year
  • BGLC N/A
  • SPPL 2023
  • Fundamental
  • Price
  • BGLC $5.52
  • SPPL $2.75
  • Analyst Decision
  • BGLC
  • SPPL
  • Analyst Count
  • BGLC 0
  • SPPL 0
  • Target Price
  • BGLC N/A
  • SPPL N/A
  • AVG Volume (30 Days)
  • BGLC 3.4M
  • SPPL 31.0K
  • Earning Date
  • BGLC 08-18-2025
  • SPPL 01-01-0001
  • Dividend Yield
  • BGLC N/A
  • SPPL N/A
  • EPS Growth
  • BGLC N/A
  • SPPL N/A
  • EPS
  • BGLC N/A
  • SPPL N/A
  • Revenue
  • BGLC $9,265,870.00
  • SPPL $2,764,846.00
  • Revenue This Year
  • BGLC N/A
  • SPPL N/A
  • Revenue Next Year
  • BGLC N/A
  • SPPL N/A
  • P/E Ratio
  • BGLC N/A
  • SPPL N/A
  • Revenue Growth
  • BGLC N/A
  • SPPL N/A
  • 52 Week Low
  • BGLC $2.01
  • SPPL $2.16
  • 52 Week High
  • BGLC $15.60
  • SPPL $16.80
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 52.81
  • SPPL 45.09
  • Support Level
  • BGLC $5.28
  • SPPL $2.71
  • Resistance Level
  • BGLC $5.85
  • SPPL $3.00
  • Average True Range (ATR)
  • BGLC 0.69
  • SPPL 0.31
  • MACD
  • BGLC -0.07
  • SPPL -0.05
  • Stochastic Oscillator
  • BGLC 29.80
  • SPPL 21.81

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: